Israel’s Immunai expands strategic tie with AstraZeneca
Israeli firm Immunai, a developer of AI-based instruments for enhancing drug discovery processes, has introduced a strategic settlement with ...
Israeli firm Immunai, a developer of AI-based instruments for enhancing drug discovery processes, has introduced a strategic settlement with ...
This part is Partnership Content material providedThe content material on this part is provided by GlobeNewswire for the needs of ...